Bronchiolitis clinical trials at UCSF
1 research study open to eligible people
Bronchiolitis is a lung infection that affects babies and children. A clinical trial is looking for ways to improve care for children hospitalized with bronchiolitis, asthma, and pneumonia. The study aims to find practical and lasting solutions for better treatment. UCSF is currently recruiting participants for this trial.
Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children
open to eligible people ages up to 17 years
This study's objective is to identify and test pragmatic and sustainable strategies for implementing a multi-condition clinical pathway intervention for children hospitalized with asthma, pneumonia, or bronchiolitis in community hospitals. The hypothesis is that the multi-condition pathway intervention will be associated with significantly greater increases in clinicians' adoption of evidence-based practices compared to control. The study is a pragmatic, cluster-randomized trial in US community hospitals. The primary outcome will be adoption of evidence-based practices over a sustained period of 2 years. Secondary outcomes include length of hospital stay, intensive care unit transfer, and hospital readmission/emergency department revisit.
San Francisco, California
Our lead scientists for Bronchiolitis research studies include Sunitha V Kaiser, MD, MSc.